Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Am J Surg. 2022 May 13;224(3):990–998. doi: 10.1016/j.amjsurg.2022.05.001

Table 2.

Comparison of balance between a propensity score matched cohort of nonrecovered potential and actual donation after cardiac death liver donors. Standardized differences greater than 0.1 in absolute value are considered significant and highlighted in bold type.

Non-Recovered Potential DCDs (n = 144) Actual DCDs (n = 144) Standardized Difference

Age 48.0 (34.0–55.0) 46.0 (35.5–54.5) −0.01
Male Gender 95 (66.0%) 97 (67.4%) −0.03
Height 174.5 (165.1–180.0) 175.0 (167.8–180.2) −0.06
Weight 80.9 (70.0–95.4) 83.1 (67.7–97.9) −0.06
BMI 27.5 (23.7–31.6) 27.3 (23.5–31.5) −0.05
AST 38.5 (25.0–58.5) 36.0 (23.0–48.0) 0.07
ALT 33.0 (20.0–48.5) 28.0 (16.0–41.0) 0.08
Total Bilirubin 0.5 (0.4–0.7) 0.5 (0.3–0.7) −0.01
Diabetes 18 (12.5%) 17 (11.9%) 0.02
Ethinicity
Caucasian 118 (81.9%) 120 (83.3%) −0.04
African American 11 (7.6%) 8 (5.6%) 0.08
Hispanic 12 (8.3%) 13 (9.0%) −0.02
Asian 2 (1.4%) 2 (1.4%) 0.00
Native American/Other 1 (0.7%) 1 (0.7%) 0.00
ABO
A 52 (36.1%) 54 (37.5%) −0.03
AB 10 (6.9%) 5 (3.5%) 0.16
B 24 (16.7%) 21 (14.6%) 0.06
O 58 (40.3%) 64 (44.4%) −0.08
Cause of Death
Anoxia 64 (44.4%) 54 (37.5%) 0.14
CVA 31 (21.5%) 35 (24.3%) −0.07
Trauma 37 (25.7%) 44 (30.6%) 0.11
Other 12 (8.3%) 11 (7.6%) 0.03
IV Drug Use 16 (11.1%) 16 (11.1%) 0.00
Withdrawal to Crossclamp Interval (minutes) 24.0 (20.0–27.0) 22.0 (19.0–22.5) 0.06
HIV NAT
Negative 139 (96.5%) 136 (94.4%) 0.09
Not Done 2 (1.4%) 3 (2.1%) −0.05
Prior to Routine Collection 3 (2.1%) 5 (3.5%) −0.08
Hepatitis C NAT
Negative 141 (97.9%) 139 (96.5%) 0.08
Prior to Routine Collection 3 (2.1%) 5 (3.5%) −0.08
Heavy Alcohol Use
No 140 (97.2%) 138 (95.8%) 0.07
Unknown 4 (2.8%) 6 (4.2%) −0.08